Description
ABBOTT PRECISION PXP GLUCOSE TEST STRIPS
First action · last action
2010-10-19 · 2010-10-19
Transactions
1
First transaction's obligation
$29,459
Base + all options value (sum of deltas)
$29,459
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5478X
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-10-19+$29,459= $29,459
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-10-19 | +$29,459 | $29,459 | ABBOTT PRECISION PXP GLUCOSE TEST STRIPS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under 6640 from 557S-DUBLIN SMALL PURCHASE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| V557A10058 | BIOMERIEUX INC | 557S-DUBLIN SMALL PURCHASE | $8,999 | FY2011 |
| V557A10003 | ORTHO-CLINICAL DIAGNOSTICS INC | 557S-DUBLIN SMALL PURCHASE | $5,165 | FY2011 |
| V557A10002 | IMMUCOR INC | 557S-DUBLIN SMALL PURCHASE | $7,651 | FY2011 |
| V557A00095 | ALL BUSINESS MACHINES, INC. | 557S-DUBLIN SMALL PURCHASE | $13,153 | FY2010 |
| V557A00092 | FISHER SCIENTIFIC COMPANY L.L.C. | 557S-DUBLIN SMALL PURCHASE | $9,260 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA557A10004_3600_V797P5478X_3600 · retrieved 2026-09-26.